|
|
Mastocytosis Resource Articles
|
Reference Articles
Akin, C. Mast cells and Mastocytosis. In: Akin, C, ed. ImmunolAllergy Clin N America 2006; 26 (3): 465-476, 487-504, 515-529, 541, 549-566.
Akin, C. Valent, P. Metcalfe, DD. Mast cell activation syndrome: proposed diagnostic criteria. J. Allergy Clin Immunol.2010;126(6): 1099-1104.
Akin,C. Valent, P. and Escribano,L. Urticaria pigmentosa and Mastocytosis: the role of immunophenotyping in diagnosis and determining response to treatment. Allergy Asthma Rep.2006; Vol 6 (4):282-288.
Brockow, K, Jofer, J, Ring, J. Anaphylaxis in patients with Mastocytosis- a prospective study on prevalence, severity, and trigger factors in 121 patients. J Allergy Clin Innumol 2010; 117 (2): x307.
Butterfield, J.H., Weiler, C.R. Prevention of mast cell activation disorder associated clinical sequelae of excessive prostaglandin D (2) production. Int. Archives of Allergy and Immunol 2008; Vol 147 (4), 338-343.
Butterfield, J., Weiler, C. R. Whole blood serotonin levels in cutaneous Mastocytosis, systemic Mastocytosis, and mast cell activation syndrome. Journal Allerg, Clin Immunol 2011; Vol 127 (2) Supplement page.
Butterfield, J., Weiler, C.R, Sridhara, S. Systemic Mastocytosis: Mayo clinic experience since 2000. Journal Allergy and Immunol 2011: Vol 127 (2) Supplement page.
Carter, M.C., et all. Pediatric Mastocytosis; routine anesthetic management for a complex disease. Anesth Analog, 2008; Vol 107 (2), 422-427.
Castells, MC. Anaphylaxis and Hypersensitivity Reactions. Springer; 2011.
Escribano, L., Akin, C., Castells M., Orfao A., and Metcalfe, D. Mastocytosis: current concepts in diagnosis and treatment. Ann Hematol. 2002; Vol 81 (12), 677-690.
Escribano, L., Akin, C., Castells M., Schwartz, L.B. Current options in the treatment of mast cell mediator-related symptoms in Mastocytosis. Inflamm Allergy Drug Targets; 2006. Vol 5 (1) 61-77.
Gotlib,J. On being metachromatic: mystique and misunderstanding Mastocytosis. Am J Hematol, 2009; 84: 779-781.
Hamilton, MJ. Hornick, JL. Akin, C. Castells, MC. Greenberger, NJ. Mast cell activation syndrome: a newly recognized disorder with systemic clinical manifestations. J Allergy Clin Immunol 2011: 128 (1): 147-152.
Hepner, D. L., Castells, M. Anaphylaxis during the perioperative period. Anesth Analg, 2003; 97 (5), 1381-1395.
Liberman, etal. The diagnosis and management of anaphylaxis practice parameter: 2010 update. J Allergy Clin Immunol 2010: 126;477-480e42.
Norred, CL. Anesthetic-induced anaphylaxis. AANA J. 2010: April, in press.
Simons, EF, et al. World Allergy Organization anaphylaxis guidelines: summary. J Allergy Clin Immunol, 2011: 127; 587-593.
Sridhara, S, Butterfield J., and Weiler, CR, Systemic Mastocytosis: Mayo clinic experience since 2000 In Press Journal of Allergy and Clinical Immunology 2010.
Sridhara, S., Weiler, C. Mastocytoma: a review of 57 patients. Annals of Allergy, Asthma & Immunology 2010:105 (Supplement 5):A127.
|
|
|
